Status:
COMPLETED
Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Congenital Bleeding Disorder
Congenital FVII Deficiency
Eligibility:
All Genders
Brief Summary
This NON INTERVENTIONAL OBSERVATIONAL STUDY is conducted in Europe. The primary aim is to observe the haemostatic efficacy of NovoSeven® treatment during routine practice in German clinics. The observ...
Eligibility Criteria
Inclusion
- Written informed consent obtained from patient or patient's legally acceptable representative in which he agrees that the patient's pseudonymised personal data will be transferred for use in a scientific evaluation and publication
Exclusion
- Due to the non-interventional observational character of the study, there are no exclusion criteria.
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT00697320
Start Date
June 1 2008
End Date
December 1 2010
Last Update
December 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Mainz, Germany, 55127